Leqembi slowed cognitive decline in a clinical trial, but the treatment is expensive and carries serious risks of brain swelling and bleeding.
from International: Top News And Analysis https://ift.tt/HKf5I7D
via IFTTT
Ticker Tape by TradingView
Thursday, July 6, 2023
FDA approves Alzheimers drug Leqembi paving way for broader Medicare coverage
Subscribe to:
Post Comments (Atom)
Ticker Tape by TradingView
No comments:
Post a Comment